Dopamine receptor gene expression changes in peripheral blood mononuclear cells from schizophrenic patients treated with haloperidol and olanzapine

European Journal of Inflammation

Volumn 7, Issue 2, 2009, Pages 71-76

  Shariati, G H ^a,b   Ahangari, G ^a   Asadi, M R ^c   Poyafard, F ^c   Ahmadkhaniha, H R ^d,e  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Dopamine gene receptor; Gene expression; Schizophrenia

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR; HALOPERIDOL; MESSENGER RNA; OLANZAPINE; RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; LYMPHOCYTE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SCHIZOPHRENIA;

EID: 69549137891     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727x0900700203     Document Type: Article

References (18)

1. AR Katritzky, Dobchev DA, Stoyanova-Slavova IB, et al. Novel computational models for predicting dopamine interactions. Exp Neurol 2008; 211:150-171
2. Grandy DK, Marchionni MA, Makam H, et al. Cloning of the cDNA and Gene for a human D2 dopamine receptor. Proc Natl Acad Sci USA 1989; 86:9762-9766 (Pubitemid 20030713)
3. Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O. Cloning of the gene for a human dopamineD4 receptor with high affinity for the antipsychotic clozapine. Nature 1991; 350:610-614 (Pubitemid 21912282)
4. Weiss EL, Longhurst JG, Bowers MB, Mazure CM. Olanzapine for treatment-refractory psychosis in patients responsive to clozapine. J Clin Psychopharmacol 1999; 19:378-380
5. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000; 157:683-694 (Pubitemid 30249643)
6. Bowden NA, Weidenhofer J, Scott RJ, et al. Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia. Schizophr Res 2006; 82:175-183 (Pubitemid 43290681)
7. Chertkow Y, Weinreb O, Youdim MB, Silver H. Gene expression changes in peripheral mononuclear cells from schizophrenic patients treated with a combination of antipsychotic with fluvoxamine. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:1356-1362 (Pubitemid 47302546)
8. Ahangari G, Tehrani M, Halapi E, Hammar H, Wigzell H. RT-PCR based analysis of T-cell receptor B variable region gene usage in normal human SKIN. Scand J Immunol 1996; 44:330-334
9. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual, Cold Spring Harbor Laboratory Press USA 2003; 433-527.
10. NCBI-National center for biotechnology information, NCBI Blast home page, Http://www.ncbi.nlm.nih.gov/Blast
11. Gladkevich A, Nelemans SA, Kauffman HF, Korf J. Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodology. Mediators Inflamm 2005; 6:317-30. (Pubitemid 41803400)
12. Miquel Bernardo, Eduard Parellada, Francisco Lomen, et al. Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint I IBZM SPECT study. Psychiatry Research: Neuroimaging Section 2001; 107:87-97.
13. Grimaldi B, Fillion G. 5-HT-moduline controls serotonergic activity: implication in neuroimmune reciprocal regulation mechanisms. Prog Neurobiol 2000; 60:1-12. (Pubitemid 30001449)
14. Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 2006; 141:261-268
15. Silver H, Nassar A, Aharon N, Kaplan A. The onset and time course of response of negative symptoms to add-on fluvoxamine treatment. Int Clin Psychopharmacol 2003; 18:87-92. (Pubitemid 36343977)
16. Kirillova GP, Hrutkay RJ, Shurin MR, Shurin GV, Tourkova IL, Vanyukov MM. Dopamine receptors in human lymphocytes: Radioligand binding and quantitative RT-PCR assays. J Neurosci Methods 2008; 174:272-280
17. Bertran-Gonzalez J, Bosch C, Maroteaux M, Matamales M, Hervé D, Valjent E, Girault JA. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 2008; 28:5671-5685
18. Padín JF, Rodríguez MA, Domínguez E, et al. Parallel regulation by olanzapine of the patterns of expression of 5-HT2A and D3 receptors in rat central nervous system and blood cells. Neuropharmacology 2006; 51:923-932 (Pubitemid 44376403)